Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older
Clinical trial NCT02045836 · COMPLETED
Trial details
- NCT number
- NCT02045836
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-05
- Primary completion
- 2015-07-02
- Enrollment
- 865
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.